Agape ATP (ATPC) EBITDA (2017 - 2026)
Agape ATP's (ATPC) quarterly EBITDA came in at $84085.0 in Q2 2026, up 113.27% year-over-year from $39427.4 in Q2 2025, and up 112.41% quarter-over-quarter from -$677372.0 in Q1 2026.
Powered by 
Analysis
Agape ATP (ATPC) EBITDA (2017 - 2026) Analysis & Trends
Agape ATP (ATPC) has reported EBITDA for 10 consecutive years, with $84085.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBITDA rose 113.27% year-over-year to $84085.0 in Q2 2026; TTM through Jun 2026 was -$2.5 million, a 9.38% increase from a year earlier, with the FY2025 full-year figure at -$3.3 million, down 26.55% from the prior year.
- EBITDA was $84085.0 for Q2 2026 at Agape ATP, up from -$677372.0 in the prior quarter.
- Over five years, EBITDA peaked at $84085.0 in Q2 2026 and troughed at -$1.3 million in Q4 2025.
- A 5-year average of -$561112.5 and a median of -$574715.5 in 2024 frame the typical range for EBITDA.
- Across the five-year window, EBITDA slumped 72.86% in 2024 and jumped 113.27% in 2026, its largest moves.
- Over 5 years, EBITDA stood at -$761543.0 in 2022, then slumped by 33.42% to -$1.0 million in 2023, then advanced by 16.53% to -$848109.0 in 2024, then sank by 53.04% to -$1.3 million in 2025, then surged by 106.48% to $84085.0 in 2026.
- The last three EBITDA figures came in at $84085.0 (Q2 2026), -$677372.0 (Q1 2026), and -$1.3 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Colgate Palmolive | 70.27 Bn | 68.90 Bn | 3.30 Bn | 1.02 Bn |
| 2 | Kenvue | 34.17 Bn | 33.06 Bn | 2.30 Bn | 699.00 Mn |
| 3 | Kimberly Clark | 32.86 Bn | 31.91 Bn | 1.60 Bn | 633.00 Mn |
| 4 | Bath & Body Works | 3.85 Bn | 3.05 Bn | 692.00 Mn | 216.00 Mn |
| 5 | Prestige Consumer Healthcare | 2.32 Bn | 2.26 Bn | - | - |
| 6 | Perrigo | 1.99 Bn | 1.59 Bn | 313.90 Mn | 23.50 Mn |
| 7 | Herbalife | 1.32 Bn | 946.20 Mn | 1.03 Bn | 128.30 Mn |
| 8 | Edgewell Personal Care | 1.24 Bn | 842.99 Mn | 242.50 Mn | 25.00 Mn |
| 9 | TFA Therapeutics | 1.02 Bn | 1.02 Bn | - | - |
| 10 | Agape ATP | 2.38 Mn | 2.38 Mn | - | 84,085.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 84,085.00 |
| Mar 31, 2026 | -677,372.00 |
| Dec 31, 2025 | -1.30 Mn |
| Sep 30, 2025 | -601,321.00 |
| Jun 30, 2025 | -633,864.00 |
| Mar 31, 2025 | -720,404.00 |
| Dec 31, 2024 | -848,109.00 |
| Sep 30, 2024 | -548,110.00 |
| Jun 30, 2024 | -453,585.00 |
| Mar 31, 2024 | -723,538.00 |
| Dec 31, 2023 | -1.02 Mn |
| Sep 30, 2023 | -317,078.00 |
| Jun 30, 2023 | -359,533.00 |
| Mar 31, 2023 | -453,885.00 |
| Dec 31, 2022 | -761,543.00 |
| Sep 30, 2022 | -193,308.00 |
| Jun 30, 2022 | -306,183.00 |
| Mar 31, 2022 | -272,232.00 |
| Dec 31, 2021 | -742,065.00 |
| Sep 30, 2021 | -364,996.00 |